Electromagnetic Field Therapy to Improve Healing of Chronically Venous Ulcer

The Effect of Electromagnetic Field Therapy to Improve Healing of Chronically Venous Ulcer in Lower Extremities

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01561170

Enrollment

Registered

2012-03-22

Start date

2011-10-31

Completion date

2015-06-30

Last updated

2015-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Venous Hypertension With Ulcer and Inflammation, Venous Ulcer Pain

Keywords

Electromagnetic, Field therapy, Chronically venous ulcer, Venous insufficiens

Brief summary

Chronically venous ulcer in lower extremities is a permanent and disabling disease. Venous insufficience is the main cause of chronic ulcer. There is a high prevalence and frequency of the disease, primarily among elderly people. Recently, electromagnetic field therapy has been tested on various diseases in musculoskeletal system with a beneficial effect. In recent years, there has been an increasing interest in using electromagnetic field therapy to treat chronically venous ulcer. The hypothesis of the investigators is that the electronic magnetic field therapy improves the healing process and reduces pain for patients suffering from chronically venous ulcer. The investigators assume that the bioactivity is affected by a cellular response which affects the DNA synthesis, transcription og protein synthesis.

Interventions

DEVICEActive Pulsed Electro-Magnetic Field (PEMF)

One group of patients receive active devices. Both patients and investigator are blinded.

DEVICEPlacebo Pulsed Electro-Magnetic Field (PEMF)

One group of patients receive placebo devices. Both patients and investigator are blinded.

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Patients who suffer from ulcer in lower extremities * Patients who suffer from venous insufficience detected by duplex scanning or by a pressure on digits \> 40 mmHg * Patients with a regular need of compression stockings * Age \> 18 years

Exclusion criteria

* Age \< 18 years * Unability to read or understand Danish * Patients who suffer from manifest neoplastic disorder

Design outcomes

Primary

Measure	Time frame	Description
Reduction of ulcerous area.	3 months	Measurement of ulcerous area in order to assessing the effect of the healing process.

Secondary

Measure	Time frame	Description
Pain reduction in proportion to Visual Analogue Scale (VAS).	3 months	The pain reduction will be measured by VAS and an analysis of the medication between the two group of patients will be carried out in order to measure quality of life, adverse effects, ulceration, granulation tissue etc.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026